Natalie J Ives

Summary

Affiliation: University of Birmingham
Country: UK

Publications

  1. pmc Statistical analysis plan for the Stroke Oxygen Study (SO₂S): a multi-center randomized controlled trial to assess whether routine oxygen supplementation in the first 72 hours after a stroke improves long-term outcome
    Julius Sim
    Health Services Research Unit, Keele University, Keele ST5 5BG, UK
    Trials 15:229. 2014
  2. pmc Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's disease (PD COMM pilot): study protocol for a randomized controlled trial
    Catherine M Sackley
    School of Rehabilitation Sciences, University of East Anglia, Earlham Road, Norwich NR4 7TJ, UK
    Trials 15:213. 2014
  3. pmc Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial
    Nicholas J A Webb
    Department of Paediatric Nephrology and NIHR Wellcome Trust Children s Clinical Research Facility, University of Manchester, Manchester Academic Health Science Centre, Royal Manchester Children s Hospital, Manchester, UK
    Trials 15:147. 2014
  4. pmc Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial
    Michael Walsh
    Departments of Medicine and Clinical Epidemiology and Biostatistics, Marian Wing, Division of Nephrology, McMaster University, St, Joseph s Hospital, 50 Charlton Ave East, Hamilton, ON L8S 4A6, Canada
    Trials 14:73. 2013
  5. pmc Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial
    Adrian Williams
    Queen Elizabeth Hospital, Birmingham, Birmingham, UK
    Lancet Neurol 9:581-91. 2010
  6. ncbi request reprint Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients
    Natalie J Ives
    Birmingham Clinical Trials Unit, Division of Medical Sciences, Robert Aitken Institute, University of Birmingham, Edgbaston, Birmingham, United Kingdom
    J Clin Oncol 25:5426-34. 2007
  7. pmc Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients
    Natalie J Ives
    Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2RR
    BMJ 329:593. 2004
  8. ncbi request reprint Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials
    Natalie J Ives
    Birmingham Clinical Trials Unit, The University of Birmingham, Park Grange, 1 Somerset Road, Edgbaston, Birmingham B15 2RR, UK
    Nephrol Dial Transplant 18:298-304. 2003
  9. pmc Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials
    Dwomoa Adu
    Department of Nephrology, Queen Elizabeth Hospital, Birmingham, B15 2TH
    BMJ 326:789. 2003
  10. ncbi request reprint Does adjuvant vaccine therapy really have activity in malignant melanoma?
    Keith Wheatley
    J Clin Oncol 25:4693; author reply 4693-5. 2007

Collaborators

  • Keith Wheatley
  • Dwomoa Adu
  • Crispin Jenkinson
  • T Foltynie
  • A Williams
  • Paul Cockwell
  • Pierre Francois Plouin
  • K Ashkan
  • Paul Lorigan
  • C E Clarke
  • Pieta Krijnen
  • Julius Sim
  • Nicholas J A Webb
  • Catherine M Sackley
  • Michael Walsh
  • Richard Gray
  • Martin Christian
  • Wendy Cook
  • Karl McKeever
  • Andrew Howman
  • Elizabeth A Brettell
  • Emma Frew
  • Christine Roffe
  • Caroline Rick
  • Debbie Kelly
  • Ania Koziell
  • Francis Dowling
  • Sue Jowett
  • Angela S Hall
  • Helen Roberts
  • Smitaa Patel
  • Marian C Brady
  • Christina H Smith
  • David V Milford
  • Shivram Hegde
  • Ramilla Patel
  • Detlef Bockenhauer
  • Moin A Saleem
  • Jenny Booth
  • Heather Maxwell
  • Tracy Nevatte
  • Caroline Jones
  • Eric R Finlay
  • Gina Sands
  • Rodney D Gilbert
  • Loic Guillevin
  • Peter A Merkel
  • Wladimir Szpirt
  • David Jayne
  • Charles D Pusey
  • Janak De Zoysa
  • Jeffrey L Winters
  • Chen Au Peh
  • Karen Quillen
  • William F Clark

Detail Information

Publications11

  1. pmc Statistical analysis plan for the Stroke Oxygen Study (SO₂S): a multi-center randomized controlled trial to assess whether routine oxygen supplementation in the first 72 hours after a stroke improves long-term outcome
    Julius Sim
    Health Services Research Unit, Keele University, Keele ST5 5BG, UK
    Trials 15:229. 2014
    ..The secondary hypothesis is that restricting oxygen supplementation to night time only is more effective than continuous supplementation. This paper describes the statistical analysis plan for the study...
  2. pmc Lee Silverman voice treatment versus standard NHS speech and language therapy versus control in Parkinson's disease (PD COMM pilot): study protocol for a randomized controlled trial
    Catherine M Sackley
    School of Rehabilitation Sciences, University of East Anglia, Earlham Road, Norwich NR4 7TJ, UK
    Trials 15:213. 2014
    ....
  3. pmc Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial
    Nicholas J A Webb
    Department of Paediatric Nephrology and NIHR Wellcome Trust Children s Clinical Research Facility, University of Manchester, Manchester Academic Health Science Centre, Royal Manchester Children s Hospital, Manchester, UK
    Trials 15:147. 2014
    ..The aim of PREDNOS 2 is to evaluate the effectiveness of a 6-day course of daily prednisolone therapy during an URTI in reducing the development of a subsequent relapse in a developed nation...
  4. pmc Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis (PEXIVAS): protocol for a randomized controlled trial
    Michael Walsh
    Departments of Medicine and Clinical Epidemiology and Biostatistics, Marian Wing, Division of Nephrology, McMaster University, St, Joseph s Hospital, 50 Charlton Ave East, Hamilton, ON L8S 4A6, Canada
    Trials 14:73. 2013
    ..A randomized study of both plasma exchange and glucocorticoids is required to evaluate plasma exchange and oral glucocorticoid dosing in patients with AAV...
  5. pmc Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial
    Adrian Williams
    Queen Elizabeth Hospital, Birmingham, Birmingham, UK
    Lancet Neurol 9:581-91. 2010
    ..We aimed to assess whether surgery and best medical therapy improved self-reported quality of life more than best medical therapy alone in patients with advanced Parkinson's disease...
  6. ncbi request reprint Chemotherapy compared with biochemotherapy for the treatment of metastatic melanoma: a meta-analysis of 18 trials involving 2,621 patients
    Natalie J Ives
    Birmingham Clinical Trials Unit, Division of Medical Sciences, Robert Aitken Institute, University of Birmingham, Edgbaston, Birmingham, United Kingdom
    J Clin Oncol 25:5426-34. 2007
    ..The only subgroup analysis performed was by type of immunotherapy, with trials divided according to whether IFN only or IFN and IL-2 were administered in the biochemotherapy arm...
  7. pmc Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients
    Natalie J Ives
    Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2RR
    BMJ 329:593. 2004
    ..To quantify more reliably the benefits and risks of monoamine oxidase type B inhibitors (MAOBIs) in early Parkinson's disease...
  8. ncbi request reprint Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials
    Natalie J Ives
    Birmingham Clinical Trials Unit, The University of Birmingham, Park Grange, 1 Somerset Road, Edgbaston, Birmingham B15 2RR, UK
    Nephrol Dial Transplant 18:298-304. 2003
    ..To study the effect of revascularization on blood pressure (BP) and serum creatinine (SCr) in patients with atherosclerotic renovascular disease (ARVD)...
  9. pmc Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials
    Dwomoa Adu
    Department of Nephrology, Queen Elizabeth Hospital, Birmingham, B15 2TH
    BMJ 326:789. 2003
    ..To study the effect of interleukin-2 receptor monoclonal antibodies on acute rejection episodes, graft loss, deaths, and rate of infection and malignancy in patients with renal transplants...
  10. ncbi request reprint Does adjuvant vaccine therapy really have activity in malignant melanoma?
    Keith Wheatley
    J Clin Oncol 25:4693; author reply 4693-5. 2007
  11. ncbi request reprint High-dose chemotherapy for breast cancer
    Keith Wheatley
    N Engl J Med 349:1476-9; author reply 1476-9. 2003